Steroid-Sparing Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps: Systematic Review and A Meta-Analysis of Randomized Controlled Trials

医学 随机对照试验 不利影响 慢性鼻-鼻窦炎 重症监护医学 荟萃分析 内科学 临床试验 梅德林 系统回顾 鼻息肉 样本量测定 科克伦合作 物理疗法 生活质量(医疗保健) 鼻窦炎 药品 安全概况
作者
Ali M. Alsudays,Yasser G Alarimah,Khaled A. Almanea,Ahmad Salman Alroqi
出处
期刊:American Journal of Rhinology & Allergy [SAGE Publishing]
卷期号:40 (3): 245-256 被引量:1
标识
DOI:10.1177/19458924251414922
摘要

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) presents significant management challenges, largely due to reliance on systemic corticosteroids (SCS) for symptom control. Advances in biologic therapies targeting type 2 inflammation have shown promise in reducing polyp burden, improving symptoms, and decreasing the need for SCSs and surgery. Objective This systematic review and meta-analysis compare the steroid-sparing efficacy of biologics and safety with other biologics or standard care in CRSwNP. Key outcomes include reducing SCS Use and drug safety. Methods We searched PubMed, Embase, Cochrane Library, Scopus, and the Web of Science. We included randomized controlled trials (RCTs) comparing biologics versus placebo/standard care in adults with CRSwNP. The primary outcomes were SCS reduction and safety. Meta-analyses, which use a statistical method called random effects models, were employed. Results This meta-analysis of seven RCTs (n = 3097) revealed that biologic therapies significantly reduce SCS use in CRSwNP patients (pooled proportion: 20.9%, 95% CI: 8.4%-37.0%), though with substantial heterogeneity (I 2 = 98.3%). Trial-level predictors included control-arm safety profiles (higher serious adverse events (SAEs) reduced treatment effects) [odds ratio (OR) 0.70]. In contrast, placebo-arm SAEs enhanced them [OR 1.81]) and sample size (larger trials showed diluted responses [OR 0.993 per patient]). These results highlight the role of trial design and baseline patient risk in determining the interest of the results. They further highlight the possibility for individualized strategies in terms of treatment and call for more in-depth studies with patient-level data to refine the steroid-sparing therapeutic strategy, providing an impetus for future work in this area. Conclusions The biologics, specifically dupilumab, represent a paradigm shift in treating CRSwNP, significantly decreasing the burden of SCS—their consistent safety and efficacy support integration into treatment algorithms for severe cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
木木 12完成签到,获得积分10
2秒前
mtxh完成签到 ,获得积分10
3秒前
放开让我学习完成签到,获得积分10
3秒前
nnn完成签到 ,获得积分10
4秒前
2316690509完成签到 ,获得积分10
5秒前
7秒前
wangyiyang0604完成签到 ,获得积分10
8秒前
春夏完成签到 ,获得积分10
8秒前
10秒前
秀丽若魔完成签到,获得积分10
10秒前
14秒前
陈淋完成签到,获得积分10
16秒前
研友_nPkKEL发布了新的文献求助10
17秒前
汉堡包的应助被季末默相依采纳,获得10
19秒前
滴滴答答发布了新的文献求助10
19秒前
Baonanza完成签到,获得积分10
20秒前
tina完成签到,获得积分10
25秒前
Lrcx完成签到 ,获得积分10
32秒前
涩费爱完成签到 ,获得积分10
33秒前
无限的丸子曾完成签到 ,获得积分10
34秒前
苗条的巧凡完成签到,获得积分10
38秒前
XiaohuaTu完成签到 ,获得积分10
38秒前
39秒前
假真真完成签到 ,获得积分10
40秒前
清淮完成签到 ,获得积分10
40秒前
夏安完成签到,获得积分10
40秒前
柿子完成签到,获得积分10
42秒前
悦耳的保温杯完成签到 ,获得积分10
45秒前
淮安石河子完成签到 ,获得积分10
46秒前
46秒前
水water完成签到 ,获得积分10
47秒前
47秒前
waveless完成签到,获得积分10
48秒前
yy完成签到,获得积分10
49秒前
zhangnan完成签到 ,获得积分10
49秒前
Sweet完成签到 ,获得积分10
51秒前
愛愛愛愛完成签到,获得积分10
51秒前
tanjuan发布了新的文献求助10
53秒前
彳亍宣完成签到 ,获得积分10
55秒前
嗡嗡声完成签到 ,获得积分10
58秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180084
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808758
捐赠科研通 7776098
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557454
邀请新用户注册赠送积分活动 2479012